Scars
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Ache Laboratorios FarmaceuticosBrazil - Anápolis
1 programSilicon-based productsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Tissue RepairCACIPLIQ20®
Cytrellis BiosystemsMCD
Ache Laboratorios FarmaceuticosSilicon-based products
Clinical Trials (3)
Total enrollment: 80 patients across 3 trials
Post-surgical Scars After the Use of CACIPLIQ20
Start: Mar 2023Est. completion: Oct 202450 patients
Phase 3Unknown
Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars
Start: Sep 2018Est. completion: Nov 201930 patients
N/ARecruiting
Efficacy Study of Two Silicon-based Products to Treat Scars
Start: Jan 2016Est. completion: Oct 20160
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 80 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.